These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22258738)

  • 1. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.
    Eom CS; Lee HK; Ye S; Park SM; Cho KH
    J Bone Miner Res; 2012 May; 27(5):1186-95. PubMed ID: 22258738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.
    Wu Q; Bencaz AF; Hentz JG; Crowell MD
    Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis.
    Kumar M; Bajpai R; Shaik AR; Srivastava S; Vohora D
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1373-1392. PubMed ID: 32556910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.
    Vangala C; Niu J; Montez-Rath ME; Yan J; Navaneethan SD; Winkelmayer WC
    Am J Kidney Dis; 2020 Mar; 75(3):351-360. PubMed ID: 31606233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.
    Shin D; Oh YH; Eom CS; Park SM
    J Neurol; 2014 Apr; 261(4):686-95. PubMed ID: 24477492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
    Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies.
    Laporte S; Chapelle C; Caillet P; Beyens MN; Bellet F; Delavenne X; Mismetti P; Bertoletti L
    Pharmacol Res; 2017 Apr; 118():19-32. PubMed ID: 27521835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
    Anglin R; Yuan Y; Moayyedi P; Tse F; Armstrong D; Leontiadis GI
    Am J Gastroenterol; 2014 Jun; 109(6):811-9. PubMed ID: 24777151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
    Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
    J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies.
    Man KK; Tong HH; Wong LY; Chan EW; Simonoff E; Wong IC
    Neurosci Biobehav Rev; 2015 Feb; 49():82-9. PubMed ID: 25498856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor: A Systematic Review and Meta-Analysis.
    Jones JS; Kimata R; Almeida OP; Hankey GJ
    Stroke; 2021 Aug; 52(9):2802-2808. PubMed ID: 34167325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.
    Bruyère O; Reginster JY
    Endocrine; 2015 Feb; 48(1):65-8. PubMed ID: 25091520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.